Levetiracetam
FDA Approved, EMA Approved
Contents
Description
Antiepileptic drug used to control seizures in patients with epilepsy, including those with structural brain abnormalities. It is commonly prescribed for patients with corpus callosum abnormalities who experience seizure disorders.
Indications & Therapeutic Use
Partial-onset seizures, myoclonic seizures, primary generalized tonic-clonic seizures, epilepsy associated with structural brain malformations
Linked Diseases:
myoclonus
G25.3D009207
Global Availability (11 countries)
Buy / Source Levetiracetam — GNH India
642 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
ACH-LEVETIRACETAM
250 MGtabletCANADA
AG-LEVETIRACETAM
250 MGtabletCANADA
APO-LEVETIRACETAM
250 MGtabletCANADA
AURO-LEVETIRACETAM
250 MGtabletCANADA
Cezarius
EU
Cinaz
EU
Desitrend
EU
Dretacen
EU
Products and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Levetiracetam
| Generic Name | Levetiracetam |
| Brands | 1 brand available |
| Active Ingredient | Levetiracetam |
| Drug Class | Partial-onset seizures |
| Manufacturer | UCB Pharma |
| Dosage Forms | Oral tablet 250mg, 500mg, 750mg, 1000mg; Oral solution 100mg/mL; IV infusion 500mg/5mL |
| Medical Code | N03AX14 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved, EMA Approved |
| Clinical Trial | NCT00150449 |
| Countries | 11 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations12 Validated Nodes